UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061338
Receipt number R000070183
Scientific Title A Prospective Single-Center Two-Group Comparative Study on the Efficacy of Intraoperative Paracervical Block for Postoperative Pain Control in Vaginally Assisted NOTES Hysterectomy
Date of disclosure of the study information 2026/04/21
Last modified on 2026/04/21 16:23:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to compare different methods of local anesthesia during uterine surgery and their effects on pain

Acronym

PLUTO study

Scientific Title

A Prospective Single-Center Two-Group Comparative Study on the Efficacy of Intraoperative Paracervical Block for Postoperative Pain Control in Vaginally Assisted NOTES Hysterectomy

Scientific Title:Acronym

PLUTO study

Region

Japan


Condition

Condition

Patients with benign uterine diseases undergoing transvaginal natural orifice transluminal endoscopic surgery (vNOTES) hysterectomy

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate whether the use of a paracervical block (PCB) in vaginally assisted natural orifice transluminal endoscopic surgery hysterectomy (VANH) reduces postoperative pain and the consumption of analgesics.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Postoperative pain assessed using the visual analog scale (VAS) at 6 hours after surgery.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

PCB with lidocaine (total 10 mL)

Interventions/Control_2

PCB with normal saline (total 10 mL) as placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

74 years-old >=

Gender

Female

Key inclusion criteria

Patients scheduled to undergo VANH who have received a written explanation of the study and provided informed consent prior to surgery.

Key exclusion criteria

Patients who did not provide informed consent
Patients with a history of hypersensitivity to local anesthetics
Patients with contraindications to general anesthesia (ASA-PS >= 3)
Patients with moderate to severe renal dysfunction (eGFR <= 50 mL/min/1.73 m2)
Patients with severe hepatic dysfunction (Child-Pugh class B or C)
Patients with chronic opioid use prior to surgery
Patients with psychiatric or cognitive conditions that may interfere with reliable VAS assessment
Patients deemed unsuitable for participation by the principal investigator

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Ai
Middle name
Last name Kogiku

Organization

Kobe City Nishi-Kobe Medical Center

Division name

Obstetrics and gynecology

Zip code

6512273

Address

5-7-1 Kojidai, Nishi-ku, Kobe, Hyogo, Japan

TEL

0789972200

Email

ai_kogiku@kcho.jp


Public contact

Name of contact person

1st name Ai
Middle name
Last name Kogiku

Organization

Kobe City Nishi-Kobe Medical Center

Division name

Obstetrics and gynecology

Zip code

6512273

Address

5-7-1 Kojidai, Nishi-ku, Kobe, Hyogo, Japan

TEL

0789972200

Homepage URL


Email

ai_kogiku@kcho.jp


Sponsor or person

Institute

Kobe City Nishi-Kobe Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe City Nishi-Kobe Medical Center

Address

5-7-1 Kojidai, Nishi-ku, Kobe, Hyogo, Japan

Tel

0789972200

Email

ai_kogiku@kcho.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 04 Month 21 Day

Date of IRB

2026 Year 03 Month 26 Day

Anticipated trial start date

2026 Year 04 Month 21 Day

Last follow-up date

2027 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 04 Month 21 Day

Last modified on

2026 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070183